What Is the Greene Climacteric Scale?
The Greene Climacteric Scale (GCS) is a validated 21-item self-report questionnaire developed by John Greene at the University of Dundee, published in final validated form in 1998. It has become one of the most widely used instruments in menopause research worldwide, used as a primary or secondary outcome measure in clinical trials evaluating hormone therapy, lifestyle interventions, and complementary approaches for menopausal symptom management.
The GCS was designed to capture the multidimensional nature of menopausal experience, which cannot be reduced to hot flushes alone. It covers five distinct domains: anxiety, depressed mood, somatic symptoms, vasomotor symptoms, and sexual dysfunction.
How the 21 Items Work
Each of the 21 items asks how much you have been bothered by a specific symptom in the past week. Responses are on a 4-point scale:
- 0 = Not at all
- 1 = A little
- 2 = Quite a bit
- 3 = Extremely
The items are grouped into five subscales:
Anxiety Subscale (Items 1–6)
Covers psychological symptoms associated with anxiety: heart beating quickly or strongly, feeling tense or nervous, difficulty concentrating, feelings of panic, difficulty getting to sleep, feelings of dread or foreboding. Maximum score: 18.
Depression Subscale (Items 7–11)
Covers depressive psychological symptoms: crying spells, irritability, feeling miserable or unhappy, anxiety about the future, loss of interest in most things. Maximum score: 15.
Somatic Subscale (Items 12–18)
Covers physical symptoms that can occur around menopause but are not directly vasomotor: tingling in hands or feet, pins and needles in hands or feet, headaches, muscle and joint aches and pains, loss of feeling in hands or feet, breathing difficulties, dizziness or faintness. Maximum score: 21.
Vasomotor Subscale (Items 19–20)
Covers the two core vasomotor symptoms most closely associated with declining estrogen: hot flushes and sweating at night (night sweats). Maximum score: 6.
Sexual Dysfunction Subscale (Item 21)
A single item covering loss of interest in sex. Maximum score: 3.
Total Score and Severity Thresholds
The total GCS score is the sum of all 21 item ratings, ranging from 0 to 63. Severity categories used in research are:
| Total score | Severity classification |
|---|---|
| 0–8 | Minimal |
| 9–16 | Mild |
| 17–28 | Moderate |
| 29–63 | Severe |
These thresholds are from Greene’s original work and have been used consistently in subsequent studies. They are intended as descriptive labels for research comparisons, not as diagnostic cut-offs for clinical treatment decisions.
Worked Example
A woman completing the GCS rates the following items:
- Item 1 (heart beating quickly): 2
- Item 4 (feelings of panic): 1
- Item 19 (hot flushes): 3
- Item 20 (night sweats): 2
- All other items: 0
Total score = 2 + 1 + 3 + 2 = 8 / 63 — Minimal symptom burden.
If the same woman rated her vasomotor items higher (item 19 = 3, item 20 = 3) and additionally rated 5 somatic items as 2, her score could rise to 3 + 3 + 10 + 1 + 2 = 19, placing her in the Moderate category.
How the GCS Compares to Other Symptom Scales
Several other instruments are used in menopause research:
- Menopause Rating Scale (MRS): 11 items, self-administered, similar subscale structure to GCS. Developed in Germany; widely used in European trials.
- Blatt-Kupperman Index: An older 11-item clinician-rated instrument. Less commonly used in contemporary research but appears in older literature.
- MENQOL (Menopause-Specific Quality of Life Questionnaire): 29 items across four domains; focuses on quality-of-life impact rather than symptom severity alone.
The GCS was chosen for our calculator because it is one of the most thoroughly validated and widely used tools, with normative data available from multiple countries, and because it distinguishes five clinically meaningful symptom domains that respond differently to different treatments.
Interpreting Your Score
A GCS score has most meaning when tracked over time, not as a single snapshot. In clinical trials, the GCS total and subscale scores are compared before and after intervention to measure treatment effect. The minimally important clinical difference (MCID) — the smallest change that patients perceive as meaningful — varies across studies but is generally considered to be around 3–5 points on the total score.
If you are using the calculator to track your own experience:
- Complete it at the same time each week for consistency
- Note which subscales are contributing most to your total score
- Share your scores with your healthcare provider as a structured way to describe your symptom experience
A high vasomotor score (items 19–20 at 3 each = 6 points) combined with a moderate psychological score often responds well to hormone therapy. A high somatic score may benefit from different approaches. Subscale patterns can help direct clinical discussions.
What the GCS Cannot Diagnose
The GCS measures subjective symptom burden. It cannot:
- Diagnose menopause, perimenopause, or premature ovarian insufficiency — these require clinical assessment and, typically, FSH levels and estradiol measurements
- Differentiate menopausal symptoms from other causes of the same symptoms (anxiety disorders, thyroid disease, sleep apnoea, cardiovascular conditions)
- Determine whether hormone therapy or other treatment is appropriate for you
All treatment decisions should be made with a qualified healthcare provider.